Harlan Levine, MD, is president of strategy and business ventures for City of Hope and a member of the CEO Council. In these roles, he is accountable for innovation, business growth, drug commercialization, payer strategies, and the Center for International Medicine. He also serves as the chairman of the board of AccessHope, City of Hope’s wholly owned subsidiary focused on serving the employer market and making leading edge cancer care available to all regardless of geography.
Prior to City of Hope, Levine held executive roles at United Health Group, Towers Watson, and Anthem, Inc., and currently or has in the past served in multiple advisory roles including Quantum Health (current), IBM’s Watson Healthcare Board of Advisors, Patient-Centered Primary Care Collaborative Board of Directors, and Medtronic for Population Health. He currently serves as a board member for BioScienceLA, Active Life Scientific, and Trapelo Health. He is a member of the Executive Advisory Council for California Lutheran University’s School of Management and is a Work Group Fellow for Health Evolution Forum’s New Models of Care Delivery.
He received his undergraduate degree from Harvard College and medical degree from University of California, San Francisco, and he is board certified in Internal Medicine.
Commencement: May 15, 2021
Click here for details!